Abstract
PURPOSE OF REVIEW: Penile prosthesis revision surgery represents a critical yet underexplored aspect of men’s health care. While primary penile prosthesis implantation offers a durable solution for erectile dysfunction unresponsive to medical therapy, complications such as infection, mechanical failure, and patient dissatisfaction often necessitate revision procedures. These surgeries are inherently more complex than primary implantations, requiring greater perioperative resources and incurring higher costs. This review synthesizes global evidence on the economic implications of penile prosthesis revision surgery, with a focus on clinical, procedural, and systemic cost drivers. RECENT FINDINGS: Evidence from both urologic and analogous surgical fields highlights the heightened resource utilization and complication rates associated with revision procedures, particularly in the presence of infection or corporal fibrosis. Device-related considerations, institutional capacity, and healthcare policy play significant roles in determining cost and accessibility. Variations in insurance coverage and access across health systems further underscore disparities in timely and equitable care. Comparative data also demonstrate that revision surgeries carry greater perioperative complexity and higher healthcare expenditure than primary implantations. SUMMARY: Penile prosthesis revision surgery should be recognized as a distinct and necessary component of sexual medicine services. Risk-adjusted reimbursement models, improved procedural coding, and regionalization of care to high-volume centers are recommended to optimize outcomes and control costs. Addressing disparities in access and ensuring cost-conscious delivery will be essential for advancing equitable and effective care in this field.